FindMyKOL

Shelly Lee, MD

Basic profile

Spokane Eye Clinic Ps

ORCIDNone on fileNPIOn fileSign in to see identifiers
✓ Itemized record
RegionSpokane, WA · WestSpecialtyOphthalmologyFocusOphthalmology
Active KOLFindMyKOL type: RegionalLatest publication2014Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Shelly Lee is an Ophthalmology physician affiliated with Spokane Eye Clinic Ps. OpenAlex indexes 6 publications with 319 citations (h-index 4).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
6publications

Publications indexed by OpenAlex. Counts exclude supporting files.

319citations

Citations across these publications.

4h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
13companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Industry payments

13 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

  • ABBVIE INC.
    Program year20254 payments
    $177
  • ANI Pharmaceuticals, Inc.
    Program year20254 payments
    $93
  • Astellas Pharma US Inc
    Program year20251 payment
    $92
All 24 payment records: search, sort and filter.Explore →

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    87.9%
    Ester Local Anesthetic87.9%
    Chloroprocaine hcl ophthalmic100%
    Part B, office-administered≥93 patients
  • Sensory organs

    10.5%
    Antineovascularisation agents9.8%
    Faricimab-svoa100%
    Part B, office-administered≥44 patients
    Vascular Endothelial Growth Factor Inhibitor0.4%
    Ranibizumab100%
    Part B, office-administered≥25 patients

    + 6 more classes in this area

  • Cancer & immunology

    1.5%
    Vascular Endothelial Growth Factor Inhibitor1%
    Aflibercept100%
    Part B, office-administered≥125 patients
    Complement Inhibitor0.5%
    Pegcetacoplan100%
    Part B, office-administered≥12 patients

    + 1 more class in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”